Provided by Tiger Fintech (Singapore) Pte. Ltd.

Aurinia Pharmaceuticals

8.21
+0.01000.12%
Post-market: 8.210.00000.00%16:41 EDT
Volume:751.10K
Turnover:6.19M
Market Cap:1.12B
PE:205.25
High:8.38
Open:8.21
Low:8.20
Close:8.20
Loading ...

Aurinia Pharmaceuticals Reports Strong 2024 Financial Growth

TIPRANKS
·
28 Feb

Aurinia Pharmaceuticals Reports Balanced Earnings with Growth and Challenges

TIPRANKS
·
28 Feb

Autoimmune Disease-Focused Aurinia Pharmaceuticals Reports Quarterly Profit, Revenue Outlook Below Expectations

Benzinga
·
28 Feb

Stock Track | Aurinia Pharmaceuticals Plummets 13.46% as Q4 Earnings and Guidance Disappoint Investors

Stock Track
·
27 Feb

Aurinia Pharmaceuticals Inc reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
27 Feb

Aurinia Pharmaceuticals Swings to Q4 Earnings, Revenue Rises

MT Newswires Live
·
27 Feb

Aurinia Pharmaceuticals (AUPH) Beats Q4 Earnings and Revenue Estimates

Zacks
·
27 Feb

Aurinia Pharmaceuticals Files Form 8-K Indicating Key Corporate Event

TIPRANKS
·
27 Feb

Aurinia: Q4 Earnings Snapshot

Associated Press Finance
·
27 Feb

Earnings Flash (AUPH) Aurinia Pharmaceuticals Posts Q4 EPS $0.01, vs. FactSet Est of $0.02 Loss

MT Newswires Live
·
27 Feb

Aurinia Pharmaceuticals Q4 2024 GAAP EPS $0.01 Beats $(0.02) Estimate, Sales $59.87M Miss $59.94M Estimate

Benzinga
·
27 Feb

BRIEF-Aurinia Pharmaceuticals Q4 Pretax Profit USD 1.173 Million

Reuters
·
27 Feb

Aurinia Pharmaceuticals Reports Financial Results for the Three and Twelve Months Ended December 31, 2024 and Provides Update on Recent Corporate Progress

THOMSON REUTERS
·
27 Feb

Aurinia Pharmaceuticals Q4 Operating Expenses USD 61.536 Million

THOMSON REUTERS
·
27 Feb

Aurinia Pharmaceuticals Inc: Outlook FY Net Product Sales in Range of $240 Mln to $250 Mln

THOMSON REUTERS
·
27 Feb

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
27 Feb

High Growth Tech Stocks In The United States Spotlighting Three Leaders

Simply Wall St.
·
26 Feb

Is Aurinia Pharmaceuticals Inc. (AUPH) the Best Small-Cap Growth Stock to Buy Now?

Insider Monkey
·
26 Feb

Aurinia Pharmaceuticals Inc expected to post a loss of 2 cents a share - Earnings Preview

Reuters
·
25 Feb

Aurinia Pharmaceuticals Inc expected to post a loss of 2 cents a share - Earnings Preview

Reuters
·
11 Feb